Our Facility
Explore ACTRIS's GMP-certified facility, equipped to develop and manufacture cell, tissue, and gene therapy products for Singapore and the ASEAN region.
About Our Facility
ACTRIS is located within the National Cancer Centre Singapore (NCCS), which houses the state-of-the-art facility. Within this facility are current Good Manufacturing Practice (cGMP) suites dedicated to meeting the growing demand for process development and manufacturing of cell, tissue, and gene therapy products (CTGTPs), alongside related translational research in Singapore and across the broader ASEAN region.
Our cGMP-certified laboratories provide the necessary space and resources for conducting critical pre-manufacturing process development activities. This enables us to identify the most optimal standard operating protocols to perform resource, time and cost-efficient manufacturing of cell, tissue, and gene therapy products.
ACTRIS has obtained Good Manufacturing Practices (GMP) certification and Manufacturer’s License (ML) from Health Sciences Authority (HSA), ensuring quality compliance in cellular therapy manufacturing and clinical services.
Our team of experienced scientists will assist you in scaling up various cell types, progressing from small-scale culture wells and flasks to cell culture bags, cell factories, and automated cell culture systems.
The facility also continues to incorporate advanced technologies to support the manufacturing of CTGT products, serving both the public and private sectors in Singapore.
Content in this section
Cell Processing and Manufacturing
Learn how our cGMP-certified facility supports the manufacture of cell, tissue, and gene therapy products for clinical trials and routine clinical access.
Quality Assurance and Quality Control
Explore the capabilities that support product safety, quality, and regulatory compliance throughout the product lifecycle.
Equipment
Explore the technologies that support the development, characterisation, and manufacture of cell, tissue, and gene therapy products.